Emma Rademaker

6PUBLICATIONS
19CO-AUTHORS
Cell development, proliferation and deathProteomics and metabolomicsInnate immunityCardiology (incl. cardiovascular diseases)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 17, 2026
Dynamic sepsis endotypes: instability or expected signal of biological progression? Author's reply.

Emma Rademaker, Harm-Jan de Grooth, Olaf L Cremer

|Dec 01, 2025
Temporal robustness of biomarker-based classification algorithms for sepsis.

Emma Rademaker, Rombout B E van Amstel, Said El Bouhaddani

|Jul 09, 2025
Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.

Emma Rademaker, Daan F L Filippini, Jelle L G Haitsma Mulier

|Dec 05, 2024
Longitudinal assessment of immunoglobulin response and disease progression in critically ill patients with community acquired pneumonia.

Emma Rademaker, Lisette M Vernooij, Tom van der Poll

|Sep 30, 2022
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.

Tessa Noordermeer, Roger E G Schutgens, Chantal Visser

|Feb 12, 2022
Thrombosis pathways in COVID-19 vs. influenza-associated ARDS: A targeted proteomics approach.

Emma Rademaker, Dennis J Doorduijn, Nuray Kusadasi

Pageof 1